NASDAQ:CRSP

Crispr Therapeutics Stock News

etoro logo Buy CRSP
*Your capital is at risk
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
While others flock to safety, should you do the opposite? Some of the best times to invest in highly speculative names are when no one wants them, as long as the reasons are macro and not company or i
Wood is bargain hunting now. And these buys may pay off big in the long run.

CRISPR Therapeutics: 2023 Could Be The Right Year

05:38am, Wednesday, 04'th Jan 2023
CRISPR Therapeutics AG is a gene editing company based on CRISPR/Cas9 technology. CRISPR method seems to be the preferred in Gene Editing.
These stocks fell significantly in 2022. But analysts expect that huge rebounds could be on the way in the new year.

3 Biotech Stocks to Watch Heading Into 2023

02:49pm, Thursday, 29'th Dec 2022
Pharma and biotech stocks are enjoying tailwinds as part of the broad market rally today.
This company has had a solid year, but there is still plenty of work ahead.
Crispr expects to make history in 2023 with a first-ever request in gene-editing technology by the same name, which could stoke shares. The post Crispr Stock In 2023: Will Down-In-The-Dumps Shares Spa
These businesses aren't in as much trouble as their stock returns suggest that they are.
These stocks could have significant upside opportunities ahead.

7 Stocks to Add to Your 10x Watchlist

12:09pm, Friday, 16'th Dec 2022
There are few things that get growth investors excited like the opportunity to invest in 10x stocks. By definition, these 10x stocks (also referred to as 10 baggers) can add huge gains to your portfol
BOSTON and ZUG, Switzerland--( BUSINESS WIRE )--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced an oral, encore presentation of clinical data
It's easier to make money in bull markets when you've done the prep work beforehand.

5 Best Bargain Stocks to Buy Before 2023

06:00am, Friday, 09'th Dec 2022
It's time to hit the best sale in town, and that involves many top stocks.
The three companies are changing the pharmaceutical industry.

Is CRISPR Therapeutics a Buy?

09:20am, Thursday, 08'th Dec 2022
A strong cash position could offset some of the near-term risks that come with owning the biotech.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE